Synaps Dx

Rockville, United States

Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.

Mar 2022

Corporate Round

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Synaps Dx's investors?

Synaps Dx's investors include Semler Scientific, Bull & Bear.

Where is Synaps Dx headquartered?

Synaps Dx is headquartered in Rockville, United States.

What does Synaps Dx do?

Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.

What stage is Synaps Dx at?

Synaps Dx is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 2, 2022.

MLA

"Synaps Dx — Funding & Investors." VCBacked, March 2, 2022, https://www.vcbacked.co/company/synaps-dx. Accessed July 1, 2026.

APA

VCBacked. (2022). Synaps Dx — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/synaps-dx

Wikipedia (cite web)

{{cite web |title=Synaps Dx — Funding & Investors |url=https://www.vcbacked.co/company/synaps-dx |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 2, 2022.